Drugs / Mycobacteriophage Muddy_HRMN0052
Mycobacteriophage Muddy_HRMN0052
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07228702 | Jan 2026 → Oct 2027 expected | pulmonary non-tuberculous mycobacterial infection | Vancouver Coastal Health | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mycobacteriophage Muddy_HRMN0052 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07228702 ↗ |
| Modality | Other / unclassified | “Bacteriophage therapy (phage therapy) involves the use of live, lytic bacteriophages” NCT07228702 ↗ |
| Route | Intravenous | “to be given IV twice daily” NCT07228702 ↗ |